[1]宣依依),杨 晶),向 勇sup>),等.类风湿关节炎小剂量甲氨蝶呤治疗药物监测及基因多态性研究进展[J].郑州大学学报(医学版),2019,(04):538-542.[doi:10.13705/j.issn.1671-6825.2018.11.077]
点击复制

类风湿关节炎小剂量甲氨蝶呤治疗药物监测及基因多态性研究进展()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2019年04期
页码:
538-542
栏目:
综述
出版日期:
2019-07-20

文章信息/Info

作者:
宣依依1)杨 晶2)向 勇<sup>3)刘升云1)
1)郑州大学第一附属医院风湿免疫科 郑州 450052;2)郑州大学第一附属医院药学部 郑州 450052;3)郑州大学第一附属医院骨科 郑州450052
关键词:
甲氨蝶呤 类风湿关节炎 治疗药物监测 基因多态性
DOI:
10.13705/j.issn.1671-6825.2018.11.077

参考文献/References:

[1] SAEVARSDOTTIR S,WALLIN H,SEDDIGHZADEH MA,et al.Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial[J].Ann Rheum Dis,2011,70(3):469
[2] GAUJOUX-VIALA C,RINCHEVAL N,DOUGADOS MA,et al.Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort[J].Ann Rheum Dis,2017,76(12):2054
[3] DERVIEUX T,FURST D,LEIN DO,et al.Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier,aminoimidazole carboxamide ribonucleotide transformylase,and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis[J].Arthritis Rheum,2004,50(9):2766
[4]DERVIEUX T,GREENSTEIN N,KREMER J.Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis[J].Arthritis Rheum,2006,54(10):3095
[5] STAMP LK,ROBERTS RL.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases[J].Pharmacogenomics,2011,12(10):1449
[6] ANGELIS-STOFORIDIS P,VAJDA FJ,CHRISTOPHIDIS N.Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis[J].Clin Exp Rheumatol,1999,17(3):313
[7] BECKER ML,VAN HAANDEL L,GAEDIGK R,et al.Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations[J].Arthritis Rheum,2010,62(6):1803
[8] DALRYMPLE JM,STAMP LK,O'DONNELL JL,et al.Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis[J].Arthritis Rheum,2008,58(11):3299
[9] BUDZIK GP,COLLETTI LM,FALTYNEK CR,et al.Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line[J].Life Sci,2000,66(23):2297
[10]ROMAO VC,CANHAO H,FONSECA JE,et al.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?[J].BMC Med,2013,11:17
[11]SHEA B,SWINDEN MV,GHOGOMU ET,et al.Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis[J]. Cochrane Database Syst Rev,2013(5):Cd000951
[12]VARANI K,PADOVAN M,GOVONI M,et al.The role of adenosine receptors in rheumatoid arthritis[J]. Autoimmun Rev,2010,10(2):61
[13]RAVANI A,VINCENZI F,BORTOLUZZI AA,et al.Role and Function of A(2A)and A(3)adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis[J].Int J Mol Sci,2017,18(4): 697
[14]VARANI K,PADOVAN M,VINCENZI F,et al.A(2A)and A(3)adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release[J].Arthritis Res Ther,2011,13(6):R197
[15]DERVIEUX T,FURST D,LEIN DO,et al.Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study[J].Ann Rheum Dis,2005,64(8):1180
[16]STAMP LK,O'DONNELL JL,CHAPMAN PT,et al.Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy[J].Arthritis Rheum,2010,62(2):359
[17]STAMP LK,BARCLAY ML,O'DONNELL JL,et al.Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis[J]. J Rheumatol,2011,38(12):2540
[18]HOBL EL,JILMA B,ERLACHER L,et al.A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate[J].Clin Exp Rheumatol,2012,30(2):156
[19]ANDO Y,SHIMADA H,MATSUMOTO N,et al.Role of methotrexate polyglutamation and reduced folate carrier 1(RFC1)gene polymorphisms in clinical assessment indexes[J].Drug Metab Pharmacokinet,2013,28(5):442
[20]DE ROTTE MC,DEN BOER E,DE JONG PH,et al.Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis[J].Ann Rheum Dis,2015,74(2):408
[21]YAMAMOTO T,SHIKANO K,NANKI T,et al.Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis[J].Sci Rep,2016,6:35615
[22]TAKAHASHI C,KANEKO Y,OKANO Y,et al.Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study[J]. RMD Open,2017,3(1):e000363
[23]LEE YC,CUI J,COSTENBADER KH,et al.Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate[J].Rheumatology(Oxford),2009,48(6):613
[24]LIMA A,MONTEIRO J,BERNARDES M,et al.Prediction of methotrexate clinical response in portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms[J].Biomed Res Int,2014,2014:368681
[25]OWEN SA,LUNT M,BOWES J,et al.MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms[J].Pharmacogenomics J,2013,13(2):137
[26]SALAZAR J,MOYA P,ALTES A,et al.Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?[J].Pharmacogenomics,2014,15(8):1079
[27]LOPEZ-RODRIGUEZ R,FERREIRO-IGLESIAS A,LIMA AA,et al.Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis[J].Sci Rep,2018,8(1):7342
[28]HIDER SL,THOMSON W,MACK LF,et al.Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX[J].Rheumatology(Oxford),2008,47(8):1156
[29]VAN DER STRAATEN RJ,WESSELS JA,VRIES-BOUWSTRA VK,et al.Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients[J].Pharmacogenomics,2007,8(2):141
[30]MOYA P,SALAZAR J,JESUS ARRANZ MA,et al.Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients[J].Pharmacogenomics,2016,17(1):25
[31]LIMA A,BERNARDES M,AZEVEDO R,et al.Moving toward personalized medicine in rheumatoid arthritis:SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome[J].Pharmacogenomics,2016,17(15):1649
[32]LIMA A,BERNARDES M,AZEVEDO R,et al.SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in portuguese rheumatoid arthritis patients[J].Toxicol Sci,2014,142(1):196
[33]LIMA A,BERNARDES M,SOUSA H,et al.SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients[J].Pharmacogenomics,2014,15(6):807
[34]LIMA A,BERNARDES M,AZEVEDO R,et al.Pharmacogenomics of methotrexate membrane transport pathway: can clinical response to methotrexate in rheumatoid arthritis be predicted?[J].Int J Mol Sci,2015,16(6):13760
[35]GOTTESMAN MM,FOJO T,BATES SE.Multidrug resistance in cancer: role of ATP-dependent transporters[J].Nat Rev Cancer,2002,2(1):48
[36]STAMP LK,O'DONNELL JL,CHAPMAN PT,et al.Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment[J].Arthritis Rheum,2009,60(8):2248

相似文献/References:

[1]刘晓利)△,董金虎).中西医联合保守治疗异位妊娠80例临床观察[J].郑州大学学报(医学版),2015,(01):146.
[2]刘运夏,朱彦锋,刘 杨,等.类风湿关节炎患者外周血Th17细胞及Treg细胞数量的meta分析[J].郑州大学学报(医学版),2015,(05):606.
 LIU Yunxia,ZHU Yanfeng,LIU Yang,et al.Quantity of Th17 and Treg cells in the peripheral blood from patients with rheumatoid arthritis:a meta analysis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(04):606.
[3]张瑞芳△,段会参,郭海燕,等.类风湿关节炎患者左室整体收缩功能的超声三维斑点追踪成像技术评价[J].郑州大学学报(医学版),2016,(05):660.
 ZHANG Ruifang,DUAN Huican,GUO Haiyan,et al.Assessment of left ventricular global systolic function in patients with rheumatoid arthritis by three-dimensional speckle tracking echocardiography[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2016,(04):660.

备注/Memo

备注/Memo:
【作者简介】刘升云,通信作者,男,1969年5月生,博士,主任医师,教授,研究方向:风湿免疫疾病的基础与临床研究,E-mail:18042257388@163.com
更新日期/Last Update: 2019-07-20